Technology advancements have enabled more treatment options for malignant lung nodules. Tapping into the well-equipped hybrid operating room at the National Infrastructure for Translational Medicine, the Department of Thoracic Surgery, PUMCH has recently combi...

Recently, the team led by Professor Li Taisheng, Director of the Department of Infectious Diseases of PUMCH, published papers in high-impact international journals, exploring the important applications pertinent to various lymphocyte subsets in immunosenescenc...

Recently, Professor Zhang Shuyang, President of PUMCH, and Professor Tian Zhuang administered YOLT-201, China’s first domestically developed gene editing drug, to the first subject in the national multi-center clinical trial at the Clinical Pharmacology Center...

On July 21, 2024, PUMCH President Zhang Shuyang and Nancy Ip, President of Hong Kong University of Science and Technology (HKUST), signed a strategic cooperation agreement as representatives. The signing was witnessed by Wu Peixin and Han Ding, Vice Presidents...